CTEV
Claritev Corporation
NYSE · USHealthcareMedical - Healthcare Information Services
$30.12-0.89%
Price as of Jul 20, 2026
CTEV profitability
Claritev Corporation profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 61.1%
- EBITDA margin
- 52.9%
- EBIT margin
- 4.3%
- Net margin
- -29.3%
- Free cash flow margin
- -3.7%
Returns
- Return on equity
- 118.8%
- Return on assets
- -5.9%
- Return on invested capital
- 1.0%
- Asset turnover
- 0.20x
Cash efficiency
- Cash from operations
- $101.6M
- Cash per share
- $1.25
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.